Tirzepatide is administered as a once-weekly subcutaneous injection, with doses ranging from 2.5 mg to 15 mg depending on therapeutic indication and individual tolerance
According to Douglas Ewing, MD, FACS, DABOM, a board-certified bariatric surgeon and medical director of the Center for Weight Loss and Metabolic Health at Hackensack University Medical Center, and associate professor of surgery at Hackensack Meridian School of Medicine in New Jersey, the FDAs 503B bulks list identifies bulk drug substances that outsourcing facilities can use to compound medications
These softer outcomes matter, since weight management is as much about mindset as metabolism
Intended Research Use & Disclaimer Semaglutide is intended solely for laboratory research
They close on what the literature tends to show at a population level, the practical considerations around monitoring and nutrition, and where the field is heading next
This month an editorial in the British Medical Journal urged for greater caution in their use